Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

AstraZeneca PLC (NASDAQ:AZN) announced a $3.5 billion investment in the US for manufacturing and R&D, highlighting its ...

AstraZeneca boss Pascal Soriot (pictured)) threw his weight behind its Chinese business despite the recent arrest of its boss ...

The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy ... Already this year, we delivered multiple high-value phase 3 readouts. LAURA expands the reach of Tagrisso in ...

We have potential value inflection points in the near term with the anticipated ... total reduced at net sales in China by fiber and the distribution entity jointly owned by FiberGen and AstraZeneca ...

Good day and thank you for standing by. Welcome to the Absci Q3 2024 Business Update Conference Call. At this time, all ...

This potential threat of substantial value destruction drives our no-moat rating ... Alnylam is developing an investigational RNAi silencer called vutrisiran, and Ionis and AstraZeneca are working on ...

BRITS on a budget are to face even higher prices at discount shops such as Aldi and Lidl because of the Chancellor’s tax raid ...

In 2023 Cullgen completed a Series C financing led by AstraZeneca-CICC Venture Capital Partnership, and also announced a strategic partnership with Astellas Pharma Inc.

Rio Tinto rose 34.5p to 4779.5p and Marks & Spencer improved by 3p to 368.2p, while AstraZeneca rallied 206p to 10,196p ...

AstraZeneca plc (NASDAQ: AZN) (Q3) EPS of $1.01, compared to 87 cents in the prior-year quarter. Shopify Inc (NYSE: SHOP) (Q3) EPS of 18 cents, compared to 17 cents in the prior-year quarter. Building ...

Qu – which according to Parsa is the fruit of a collaboration between a global team of experienced AI scientists, ...